Sky News
@skynews·9.3M subscribers·76.1K videos
Pioneering Alzheimer's drug rejected for widespread use in NHS in England
Posted
October 23, 2024
Views
2,264
Likes
22
Comments
10
Engagement
1.41%
October 23, 2024
2,264
22
10
1.41%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:30Now PlayingA new pioneering Alzheimer's drug has been rejected for widespread use in the NHS in England.
The announcement comes as the UK's medicines regulator said that donanemab could be licensed for use in the UK.
However, the health spending watchdog, the National Institute of Health and Care Excellence (NICE), said that it "does not currently demonstrate value for the NHS".
#alzheimers #health #nhs
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our appsApple Android
Sky News Daily podcast is available for free here
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
